Association of helicobacter pylori with parkinson’s disease

Journal of Clinical Neurology (Korea)

Volumn 13, Issue 2, 2017, Pages 181-186

  Mridula, Kandadai Rukmini ^a   Borgohain, Rupam ^a   Reddy, Vupparalli Chandrasekhar ^b   Bandaru, Venkata Chandrasekhar Srinivasarao ^c   Suryaprabha, Turaga ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

^b Nizamabad Neuro Super Specialty Hospital   (India)

^c Yashoda Hospital   (India)

Author keywords

H. pylori infection; Indian patients; Parkinson s disease; Prevalence; Triple therapy

Indexed keywords

EID: 85017519336     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2017.13.2.181     Document Type: Article

References (31)

1. Nielsen HH, Qiu J, Friis S, Wermuth L, Ritz B. Treatment for Helicobacter pylori infection and risk of Parkinson’s disease in Denmark. Eur J Neurol 2012;19:864-869.
2. Gupta BM, Bala A. Parkinson’s disease in India: an analysis of publications output during 2002-2011. Int J Nutr Pharmacol Neurol Dis 2013; 3:254–262.
3. Gourie-Devi M. Epidemiology of neurological disorders in India: review of background, prevalence and incidence of epilepsy, stroke, Parkinson’s disease and tremors. Neurol India 2014;62:588-598.
4. Wu YH, Liao YC, Chen YH, Chang MH, Lin CH. Risk of premotor symptoms in patients with newly diagnosed PD: a nationwide, population-based, case-control study in Taiwan. PLoS One 2015;10: e0130282.
5. Nafisah W, Najman A, Hamizah R, Azmin S, Rabani R. High prevalence of Helicobacter pylori infection in Malaysian Parkinson’s disease patients. J Parkinsonism Restless Legs Syndr 2013;3:63-67.
6. Goodwin CS, Armstrong JA, Chilvers T, Peters M, Collins MD, Sly L, et al. Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov. and Helicobacter mustelae comb. nov., respectively. Int J Syst Evol Microbiol 1989;39:397-405.
7. Johnson A, Kratz B, Scanlon L, Spivak A. Guts & glory H. pylori: cause of peptic ulcer. Eukaryon 2007;3:67-74.
8. Nisha KJ, Nandakumar K, Shenoy KT, Janam P. Periodontal disease and Helicobacter pylori infection: a community-based study using serology and rapid urease test. J Investig Clin Dent 2016;7:37-45.
9. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
10. Aggarwal OP, Bhasin SK, Sharma AK, Chhabra P, Aggarwal K, Rajoura OP. A new instrument (scale) for measuring the socioeconomic status of a family: preliminary study. Indian J Community Med 2005; 30:111-114.
11. Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 2004;19:1020-1028.
12. Papapetropoulos SS. Patient diaries as a clinical endpoint in Parkinson’s disease clinical trials. CNS Neurosci Ther 2012;18:380-387.
13. Dobbs RJ, Dobbs SM, Weller C, Bjarnason IT, Oxlade NL, Charlett A, et al. Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 1: eradication of Helicobacter in the cachexia of idiopathic parkinsonism. Helicobacter 2005;10:267-275.
14. Dobbs SM, Dobbs RJ, Weller C, Charlett A, Bjarnason IT, Lawson AJ, et al. Differential effect of Helicobacter pylori eradication on timetrends in brady/hypokinesia and rigidity in idiopathic parkinsonism. Helicobacter 2010;15:279-294.
15. Pierantozzi M, Pietroiusti A, Brusa L, Galati S, Stefani A, Lunardi G, et al. Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations. Neurology 2006;66:1824-1829.
16. Lee WY, Yoon WT, Shin HY, Jeon SH, Rhee PL. Helicobacter pylori infection and motor fluctuations in patients with Parkinson’s disease. Mov Disord 2008;23:1696-1700.
17. Choudhuri G, Mohindra S. Epidemiology of Helicobacter pylori in India. Indian J Gastroenterol 2000;19(Suppl 1) S3-S6.
18. Blaecher C, Smet A, Flahou B, Pasmans F, Ducatelle R, Taylor D, et al. Significantly higher frequency of Helicobacter suis in patients with idiopathic parkinsonism than in control patients. Aliment Pharmacol Ther 2013;38:1347-1353.
19. Bu XL, Wang X, Xiang Y, Shen LL, Wang QH, Liu YH, et al. The association between infectious burden and Parkinson’s disease: a casecontrol study. Parkinsonism Relat Disord 2015;21:877-881.
20. Schulz JD, Hawkes E, Shaw CA. Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator. Med Hypotheses 2006;66:1222-1226.
21. Soykan I, Lin Z, Bennett JP, McCallum RW. Gastric myoelectrical activity in patients with Parkinson’s disease: evidence of a primary gastric abnormality. Dig Dis Sci 1999;44:927-931.
22. Freestone PP, Lyte M. Microbial endocrinology: experimental design issues in the study of interkingdom signalling in infectious disease. Adv Appl Microbiol 2008;64:75-105.
23. Hashim H, Azmin S, Razlan H, Yahya NW, Tan HJ, Manaf MR, et al. Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson’s disease. PLoS One 2014;9:e112330.
24. Bjarnason IT, Charlett A, Dobbs RJ, Dobbs SM, Ibrahim MA, Kerwin RW, et al. Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 2: response of facets of clinical idiopathic parkinsonism to Helicobacter pylori eradication. A randomized, double-blind, placebocontrolled efficacy study. Helicobacter 2005;10:276-287.
25. Weller C, Oxlade N, Dobbs SM, Dobbs RJ, Charlett A, Bjarnason IT. Role of inflammation in gastrointestinal tract in aetiology and pathogenesis of idiopathic parkinsonism. FEMS Immunol Med Microbiol 2005;44:129-135.
26. Gupta A, Reddy BV, Mishra SS. Infectious causation of Parkinsonism: a review. J Dent Med Sci 2012;3:1-3.
27. Arismendi-Morillo G, Hernández I, Mengual E, Fuenmayor A, Romero G, Lizarzábal M. Comparison of three methods based on endoscopic gastric biopsies for diagnosis of Helicobacter pylori active infection in a clinical setting. Arq Gastroenterol 2011;48:190-194.
28. Mégraud F, Floch P, Labenz J, Lehours P. Diagnostic of Helicobacter pylori infection. Helicobacter 2016;21 Suppl 1:8-13.
29. Vagarali MA, Metgud SC, Bannur H, Karadesai SG, Nagmoti JM. Clinical significance of various diagnostic techniques and emerging antimicrobial resistance pattern of Helicobacter Pylori from gastric biopsy samples. Indian J Med Microbiol 2015;33:560-564.
30. Gehlot V, Mahant S, Mukhopadhyay AK, Das K, Alam J, Ghosh P, et al. Low prevalence of clarithromycin-resistant Helicobacter pylori isolates with A2143G point mutation in the 23S rRNA gene in North India. J Glob Antimicrob Resist 2016;6:39-43.
31. Goetz CG, Wuu J, McDermott MP, Adler CH, Fahn S, Freed CR, et al. Placebo response in Parkinson’s disease: comparisons among 11 trials covering medical and surgical interventions. Mov Disord 2008;23:690-699.